Huntleigh Advisors, Inc. Castle Biosciences Inc Transaction History
Huntleigh Advisors, Inc.
- $171 Billion
- Q1 2025
Shares
1 transactions
Others Institutions Holding CSTL
# of Institutions
204Shares Held
26.2MCall Options Held
128KPut Options Held
35.4K-
Black Rock Inc. New York, NY3.04MShares$57.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.83MShares$34.4 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.8MShares$33.7 Million0.24% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.47MShares$27.5 Million0.02% of portfolio
-
Dimensional Fund Advisors LP Austin, TX999KShares$18.7 Million0.01% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $493M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...